
NeuroForge
GHRH · VISCERAL
Stabilized GHRH analog engineered around visceral-adipose signalling. Clinically characterized peptide; positioned within protocols where body composition is the primary outcome.
Protocol
Reconstitute with 2 mL of bacteriostatic water. Typical research cadence: 1-2 mg subcutaneously, once daily in the evening. Store reconstituted vial refrigerated; use within thirty days. Rotate injection sites. Research use only until supplied with an applicable prescription.
40 in stock